These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 1758878

  • 1. Immunocytochemical detection of p53 in human gliomas.
    Bruner JM, Saya H, Moser RP.
    Mod Pathol; 1991 Sep; 4(5):671-4. PubMed ID: 1758878
    [Abstract] [Full Text] [Related]

  • 2. Expression of the p53 protein in a spectrum of astrocytic tumours.
    Ellison DW, Gatter KC, Steart PV, Lane DP, Weller RO.
    J Pathol; 1992 Dec; 168(4):383-6. PubMed ID: 1336544
    [Abstract] [Full Text] [Related]

  • 3. Chromosome 17 allelic loss in astrocytic tumors and its clinico-pathologic implications.
    Muhammad AK, Yoshimine T, Maruno M, Tokiyoshi K, Takemoto O, Ninomiya H, Hayakawa T.
    Clin Neuropathol; 1997 Dec; 16(4):220-6. PubMed ID: 9266149
    [Abstract] [Full Text] [Related]

  • 4. Genetic alterations associated with glioma progression.
    Kleihues P, Lübbe J, Watanabe K, von Ammon K, Ohgaki H.
    Verh Dtsch Ges Pathol; 1994 Dec; 78():43-7. PubMed ID: 7534015
    [Abstract] [Full Text] [Related]

  • 5. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
    Nayak A, Ralte AM, Sharma MC, Singh VP, Mahapatra AK, Mehta VS, Sarkar C.
    Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
    [Abstract] [Full Text] [Related]

  • 6. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
    Tada M, Iggo RD, Waridel F, Nozaki M, Matsumoto R, Sawamura Y, Shinohe Y, Ikeda J, Abe H.
    Mol Carcinog; 1997 Mar 01; 18(3):171-6. PubMed ID: 9115587
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
    Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan ZL, Liotta LA, Nicolson GL, Rao JS.
    Cancer Res; 1996 Jan 15; 56(2):384-92. PubMed ID: 8542596
    [Abstract] [Full Text] [Related]

  • 11. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region.
    Nakamura H, Yoshida M, Tsuiki H, Ito K, Ueno M, Nakao M, Oka K, Tada M, Kochi M, Kuratsu J, Ushio Y, Saya H.
    Oncogene; 1998 Feb 26; 16(8):1009-19. PubMed ID: 9519875
    [Abstract] [Full Text] [Related]

  • 12. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N.
    Neuro Oncol; 2007 Apr 26; 9(2):113-23. PubMed ID: 17327574
    [Abstract] [Full Text] [Related]

  • 13. p53 protein immunostaining in routinely processed paraffin-embedded sections.
    Bruner JM, Connelly JH, Saya H.
    Mod Pathol; 1993 Mar 26; 6(2):189-94. PubMed ID: 8483890
    [Abstract] [Full Text] [Related]

  • 14. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours.
    Chattopadhyay P, Rathore A, Mathur M, Sarkar C, Mahapatra AK, Sinha S.
    Oncogene; 1997 Aug 14; 15(7):871-4. PubMed ID: 9266974
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
    Watanabe K, Sato K, Biernat W, Tachibana O, von Ammon K, Ogata N, Yonekawa Y, Kleihues P, Ohgaki H.
    Clin Cancer Res; 1997 Apr 14; 3(4):523-30. PubMed ID: 9815715
    [Abstract] [Full Text] [Related]

  • 18. [An immunohistochemical study of the expression of the oncoprotein p53 in astrocytic gliomas of the cerebral hemispheres].
    Korshunov AG, Sycheva RV.
    Arkh Patol; 1996 Apr 14; 58(6):37-42. PubMed ID: 9139592
    [Abstract] [Full Text] [Related]

  • 19. [Expression of glial fibrillary acidic protein and protein S-100 in cerebral astrocytic gliomas of varying degrees of malignancy (immunohistochemical study)].
    Korshunov AG, Sycheva RV.
    Arkh Patol; 1995 Apr 14; 57(4):30-8. PubMed ID: 8526753
    [Abstract] [Full Text] [Related]

  • 20. Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors.
    Ren ZP, Olofsson T, Qu M, Hesselager G, Soussi T, Kalimo H, Smits A, Nistér M.
    J Neuropathol Exp Neurol; 2007 Oct 14; 66(10):944-54. PubMed ID: 17917588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.